Anti-Inflammatory and Cytokine Regulation BPC-157 downregulates pro-inflammatory mediators including: Tumor Necrosis Factor-Alpha (TNF-) Interleukin-1 Beta (IL-1) Interleukin-6 (IL-6) Leukotrienes key drivers of pain and inflammation in arthritis and tendinopathy Growth Hormone Receptor Upregulation Emerging research suggests BPC-157 increases growth hormone receptor density in injured tissues, amplifying the natural repair signals that decline with age or chronic inflammation
PMID: 33318442 Tkalcevi VI, et al
Considering the good response to the first multimodal treatment, we decided to schedule subsequent treatment cycles of oral and topical treatment for 24 months, using the same agents and doses and reducing the frequency of peri-plaque penile injections with pentoxifylline 100 mg to one penile injection every month for 12 months (second cycle) and subsequently, we further reduced the frequency of penile injections to one injection every 2 months for 12 months (third cycle)
The patience required during dose escalation is actually one of the most valuable aspects of the protocol
When you nourish your body with the right nutrients, it shows
Vitamin B12 injections are considered very safe, but this precaution must still be followed and without exception